Trial intelligence / Profile preview

n-3 PUFAs in nonischemic dilated cardiomyopathy

NCT01223703Phase 3Completed

Sponsor
University of Brescia
Start
Nov 2007
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of omega-3-acid triglycerides in dilated cardiomyopathy (DCM), heart failure (HF), sponsored by University of Brescia. Started Nov 2007; status: completed.

02

Drugs

omega-3-acid triglycerides
03

Conditions

dilated cardiomyopathy (DCM)heart failure (HF)

Beyond the preview

Go deeper on NCT01223703.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01223703.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call